Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,449 | 77 | 62.8% |
| Travel and Lodging | $1,450 | 4 | 37.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $3,410 | 68 | $0 (2024) |
| Medtronic USA, Inc. | $211.64 | 3 | $0 (2020) |
| Nevro Corp. | $111.09 | 1 | $0 (2017) |
| SI-BONE, INC. | $44.62 | 1 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $38.77 | 2 | $0 (2021) |
| Collegium Pharmaceutical, Inc. | $30.95 | 2 | $0 (2020) |
| Averitas Pharma Inc. | $16.41 | 1 | $0 (2023) |
| Curonix LLC | $15.40 | 1 | $0 (2024) |
| PFIZER INC. | $12.10 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240.47 | 5 | Abbott Laboratories ($180.45) |
| 2023 | $293.89 | 9 | Abbott Laboratories ($277.48) |
| 2022 | $480.54 | 16 | Abbott Laboratories ($480.54) |
| 2021 | $264.51 | 10 | Abbott Laboratories ($218.57) |
| 2020 | $1,982 | 26 | Abbott Laboratories ($1,792) |
| 2019 | $348.12 | 12 | Abbott Laboratories ($320.55) |
| 2018 | $140.36 | 1 | Abbott Laboratories ($140.36) |
| 2017 | $148.56 | 2 | Nevro Corp. ($111.09) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/05/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Neuromodulation | ||||||
| 06/25/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: Neuromodulation | ||||||
| 04/26/2024 | SI-BONE, INC. | — | Food and Beverage | Cash or cash equivalent | $44.62 | General |
| 03/26/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $158.65 | General |
| Category: Neuromodulation | ||||||
| 03/08/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/19/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $120.81 | General |
| Category: Neuromodulation | ||||||
| 10/20/2023 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $16.41 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/12/2023 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Neuromodulation | ||||||
| 08/17/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $7.26 | General |
| Category: Neuromodulation | ||||||
| 08/17/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $3.13 | General |
| Category: Neuromodulation | ||||||
| 06/07/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $101.16 | General |
| Category: Neuromodulation | ||||||
| 06/07/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: Neuromodulation | ||||||
| 02/28/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: Neuromodulation | ||||||
| 02/01/2023 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $7.44 | General |
| Category: Neuromodulation | ||||||
| 12/07/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $57.28 | General |
| Category: Neuromodulation | ||||||
| 12/06/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Neuromodulation | ||||||
| 11/29/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Neuromodulation | ||||||
| 11/14/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $8.04 | General |
| Category: Neuromodulation | ||||||
| 11/14/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $6.08 | General |
| Category: Neuromodulation | ||||||
| 10/12/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $7.50 | General |
| Category: Neuromodulation | ||||||
| 09/15/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $58.40 | General |
| Category: Neuromodulation | ||||||
| 09/15/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $33.25 | General |
| Category: Neuromodulation | ||||||
| 09/15/2022 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $6.02 | General |
| Category: Neuromodulation | ||||||
| 09/14/2022 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $11.72 | General |
| Category: Neuromodulation | ||||||
| 08/10/2022 | Abbott Laboratories | PRODIGY (Device) | Food and Beverage | In-kind items and services | $36.08 | General |
| Category: Neuromodulation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,932 | 9,422 | $1.9M | $339,586 |
| 2022 | 33 | 3,398 | 11,198 | $2.2M | $428,945 |
| 2021 | 33 | 3,006 | 8,269 | $2.0M | $420,961 |
| 2020 | 24 | 1,851 | 5,785 | $1.2M | $280,247 |
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 198 | 326 | $326,000 | $50,028 | 15.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 387 | 870 | $345,825 | $49,436 | 14.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 171 | 255 | $283,688 | $45,734 | 16.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 267 | 547 | $114,870 | $32,725 | 28.5% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 94 | 238 | $107,372 | $25,606 | 23.8% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 55 | 94 | $92,026 | $17,306 | 18.8% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Office | 2023 | 247 | 440 | $109,450 | $15,666 | 14.3% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 34 | 42 | $53,338 | $13,330 | 25.0% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 43 | 61 | $58,400 | $12,581 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 127 | $53,181 | $10,885 | 20.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 53 | 75 | $76,875 | $9,790 | 12.7% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 34 | 56 | $39,750 | $9,751 | 24.5% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Office | 2023 | 13 | 14 | $12,558 | $9,619 | 76.6% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 22 | 38 | $30,975 | $5,240 | 16.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $22,480 | $4,659 | 20.7% |
| 64624 | Destruction of nerve branches of knee using imaging guidance | Office | 2023 | 14 | 15 | $22,230 | $4,290 | 19.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 60 | 87 | $29,871 | $4,024 | 13.5% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 12 | 19 | $15,925 | $2,683 | 16.8% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 19 | 34 | $18,750 | $2,553 | 13.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 32 | 32 | $9,750 | $2,459 | 25.2% |
| 64454 | Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | Office | 2023 | 13 | 15 | $11,250 | $2,443 | 21.7% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 17 | 35 | $11,375 | $1,417 | 12.5% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 15 | 16 | $2,979 | $1,362 | 45.7% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2023 | 11 | 18 | $10,750 | $1,297 | 12.1% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 14 | 20 | $8,000 | $1,150 | 14.4% |
About Dr. Matthew Drakeley, M.D
Dr. Matthew Drakeley, M.D is a Pain Medicine healthcare provider based in Coraopolis, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1962820373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Drakeley, M.D has received a total of $3,898 in payments from pharmaceutical and medical device companies, with $240.47 received in 2024. These payments were reported across 81 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,449).
As a Medicare-enrolled provider, Drakeley has provided services to 11,187 Medicare beneficiaries, totaling 34,674 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Location Coraopolis, PA
- Active Since 04/02/2014
- Last Updated 09/19/2025
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1962820373
Products in Payments
- Proclaim Family of SCS IPGs (Device) $2,023
- PROCLAIM (Device) $457.37
- ETERNA (Device) $314.56
- Proclaim IPG (Device) $209.90
- INTELLIS (Device) $174.17
- Axium Sheath Braided DRG (Device) $140.36
- Senza Spinal Cord Stimulation System (Device) $111.09
- Octrode SCS Leads (Device) $98.31
- OCTRODE (Device) $77.20
- AXIUM (Device) $53.26
- NURTEC ODT (Drug) $38.77
- RESTORE (Device) $37.47
- PRODIGY (Device) $36.08
- XTAMPZA (Drug) $30.95
- QUTENZA (Drug) $16.41
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $15.40
- LYRICA (Drug) $12.10
- NALOCET (Drug) $7.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.